In mice with diabetic cardiomyopathy, inhibition of ADAM17 ameliorated fibrosis and apoptosis, whereas ADAM17 deficiency increased cell viability (Xue et al., 2022). The gene discussed is ADAM17; the disease is diabetic cardiomyopathy.